How a saliva test result for endometriosis affects pain, mood and quality of life
Compares people with and without an endometriosis diagnosis after a saliva test.
Plain-language title generated from the registry record
Registry title: Impact of a Diagnosis or Lack of a Diagnosis of Endometriosis Via a Saliva Test on Pain Catastrophizing, Quality of Life, Symptoms of Anxiety and Depression, and Treatment Adherence
Key facts
- Where
- Lille, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 43 years old?
Source: NCT07915765, who can take part
Where in France
- CHU de LilleLille, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Lille
- Trial code
- NCT07915765
- Record updated
- 4 November 2026
- Original description
This non-interventional study aims to assess the impact of an endometriosis diagnosis obtained through a salivary test (Ziwig Endotest®) on pain-related cognitions, quality of life, mood, and treatment adherence, comparingthese outcomes with those of individuals who underwent the same salivary test but received a negative result and were therefore not diagnosed with endometriosis.Read full original descriptionShow less
Impact of a Diagnosis or Lack of a Diagnosis of Endometriosis Via a Saliva Test on Pain Catastrophizing, Quality of Life, Symptoms of Anxiety and Depression, and Treatment Adherence
This non-interventional study aims to assess the impact of an endometriosis diagnosis obtained through a salivary test (Ziwig Endotest®) on pain-related cognitions, quality of life, mood, and treatment adherence, comparingthese outcomes with those of individuals who underwent the same salivary test but received a negative result and were therefore not diagnosed with endometriosis.
Participation in this study will contribute to advancing research in the field of endometriosis diagnosis and multidisciplinary management by expanding current knowledge of diagnostic protocols and their impact on pain, quality of life, treatment adherence, and potential psychiatric comorbidities. The investigators hope to enhance understanding of endometriosis and pelvic pain symptomatology in order to develop new therapeutic strategies, including psychological interventions or integrated psychological care, that better address the needs and specific characteristics of patients whether or not they receive a diagnosis of endometriosis.
Inclusion: Patients eligible for an endotest as part of the innovation package at Jeanne de Flandre Hospital; Patients between 18 to 43 years old; Understand and can communicate in French; Having received medical images that do not allow the diagnosis of endometriosis; Presenting with symptoms suggestive of endometriosis; Giving oral non-opposition to participe in the study; Beneficiary of health insurance coverage; Having normal visual and auditory acuity or corrected to normal levels.
Exclusion: Refusal to participate after receiving clear and fair information about the study; Use of psychotropic medications; Personal history of neurological disorders or current neurological disorder; Personal history of psychiatric disorders or current psychiatric disorders other than anxiety, depressive, or trauma- and stress-related disorders; Minors, adults under guardianship, under judicial protection, and persons deprived of liberty; Sensory, visual or auditory inability to participate in the study; Consumtion of toxic substances other than tobacco and alcohol; Pregnant or breastfeeding women.